iVeena Delivery Systems

Salt Lake City, United States Founded: 2012 • Age: 14 yrs
Ocular drug products for drop-free cataract surgery are developed.

About iVeena Delivery Systems

iVeena Delivery Systems is a company based in Salt Lake City (United States) founded in 2012.. iVeena Delivery Systems has raised $6.43 million across 10 funding rounds from investors including HHS, unknown and Park City Angels. iVeena Delivery Systems offers products and services including IVMED-80 and IVMED-85. iVeena Delivery Systems operates in a competitive market with competitors including Eyenovia, Kedalion Thera, PolyActiva, Re-Vana Therapeutics and MgShell, among others.

  • Headquarter Salt Lake City, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Iveena Delivery Systems, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $6.43 M (USD)

    in 10 rounds

  • Latest Funding Round
    $3 M (USD), Series B

    Feb 05, 2025

  • Investors
    HHS

    & 2 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of iVeena Delivery Systems

iVeena Delivery Systems offers a comprehensive portfolio of products and services, including IVMED-80 and IVMED-85. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Eye drops designed to treat keratoconus and granted orphan drug designation.

Eye drops for treating pediatric myopia through pharmacologic interventions.

People of iVeena Delivery Systems
Headcount 1-10
Employee Profiles 3
Board Members and Advisors 10
Employee Profiles
People
Gerald Simmons
CEO, Board Director
People
Sarah Molokhia
VP, Research & Development
People
Ned Weinshenker
COO & Director

Unlock access to complete

Board Members and Advisors
people
Vance Thompson
Scientific Advisor
people
Richard Lindstrom
Scientific Advisor
people
Jerry Hu
Scientific Advisor
people
Edward Holland
Scientific Advisor

Unlock access to complete

Funding Insights of iVeena Delivery Systems

iVeena Delivery Systems has successfully raised a total of $6.43M across 10 strategic funding rounds. The most recent funding activity was a Series B round of $3 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 10
  • Last Round Series B — $3.0M
  • First Round
  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2025 Amount Series B - iVeena Delivery Systems Valuation

investors

Sep, 2023 Amount Grant - iVeena Delivery Systems Valuation

investors

HHS
Sep, 2020 Amount Grant - iVeena Delivery Systems Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in iVeena Delivery Systems

iVeena Delivery Systems has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, unknown and Park City Angels. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by iVeena Delivery Systems

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - iVeena Delivery Systems

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Iveena Delivery Systems Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of iVeena Delivery Systems

iVeena Delivery Systems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eyenovia, Kedalion Thera, PolyActiva, Re-Vana Therapeutics and MgShell, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Microdose therapies for myopia treatment are developed with Optejet dispenser.
domain founded_year HQ Location
Provider of drug delivery system for eye diseases
domain founded_year HQ Location
A platform for slow-release, site-specific drug delivery is developed.
domain founded_year HQ Location
Drug delivery platform for ophthalmic diseases is developed.
domain founded_year HQ Location
An intraocular device for targeted drug delivery is developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Iveena Delivery Systems

Frequently Asked Questions about iVeena Delivery Systems

When was iVeena Delivery Systems founded?

iVeena Delivery Systems was founded in 2012 and raised its 1st funding round 3 years after it was founded.

Where is iVeena Delivery Systems located?

iVeena Delivery Systems is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.

Is iVeena Delivery Systems a funded company?

iVeena Delivery Systems is a funded company, having raised a total of $6.43M across 10 funding rounds to date. The company's 1st funding round was a Grant of $1.68M, raised on Apr 30, 2015.

What does iVeena Delivery Systems do?

iVeena Delivery Systems was founded in 2012 in Salt Lake City, United States, within the ocular pharmaceuticals sector. Drug products are developed to remove the need for post-operative eye drops and injections. A bioerodible dexamethasone implant (BDI) is employed to deliver medication to both the anterior and posterior eye segments during cataract procedures. Lead candidates IVMED-10 and IVMED-20 are designed for inflammation control after cataract surgery.

Who are the top competitors of iVeena Delivery Systems?

iVeena Delivery Systems's top competitors include Eyenovia, PolyActiva and Re-Vana Therapeutics.

What products or services does iVeena Delivery Systems offer?

iVeena Delivery Systems offers IVMED-80 and IVMED-85.

Who are iVeena Delivery Systems's investors?

iVeena Delivery Systems has 3 investors. Key investors include HHS, unknown, and Park City Angels.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available